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208Abstract
Several studies have addressed cytokine gene polymorphisms and their possible associations with
periodontitis. We examined the association between salivary anti‐ and pro‐inflammatory media-
tor polymorphisms and initial periodontitis in Finnish adolescents, taking into account the effect
of smoking. Salivary samples of 93 clinically examined adolescents from Eastern Finlandwere ana-
lyzed. Their oral health and smoking habits were recorded. Periodontal probing depth (PPD), and
bleeding on probing (BOP) at four sites per tooth, root calculus (RC), and visible plaque index (VPI)
were recorded from the index teeth. SalivaryMMP‐8median values were assessed. The sites with
≥4 mm PDwere categorized as follows: PPD1 = one or more ≥4 mm pocket, PPD2 = two or more
≥4 mm pockets, and PPD3 = three or more ≥4 mm pockets. Genomic DNA was extracted from
300 μl of the saliva samples by genomic QIAamp® DNA Blood Mini Kit and genotyped for
polymorphisms. Genetic variants for genotyping were selected from the following genes of
interest: S100A8, FCGR2A, FCGR2B, IL10, MMP8, MMP3, MMP13, VDR, TLR4, MMP2, MPO,
ELANE, IL1A, IL1B, IL1RN, CD28, MMP9, DDX39B, NFKBIL1, LTA, TNF, SOD2, IL6, TLR4, TIMP1,
and SYN1. After false discovery rate control (FDR), polymorphisms in MMP3 (rs679620,
rs520540, rs639752), CD28 (rs3116496), and VDR (rs2228570) associated (FDR q < 0.05) with
deepened periodontal pockets. Smoking did not affect the results. Genetic polymorphisms of
pro‐inflammatory mediators MMP3, CD28, and VDR seem to link to initial periodontitis.
KEYWORDS
adolescent, genetic, periodontitis, polymorphismPeriodontitis is a complex chronic low‐grade infection‐induced tissue
destruction inflammatory disease involving environmental factors such
as smoking. The potential periodontal pathogens activate matrix
metalloproteinases (MMPs), pro‐inflammatory cytokines, and their regu-
lators together with enhanced inflammatory burden (Sorsa et al., 2016).
The pathophysiology of periodontitis is associated with variations in
multiple disease modifying genes. The environmental factors may thus
interact with genetics (Laine, Crielaard, & Loos, 2012), and smoking as
a confounding factor needs to be taken into account when assessing
the effect of immune system and host response in periodontitis patients.
Several studies have been published regarding cytokine gene
polymorphisms and their possible associations with periodontitisCreative Commons Attribution Li
tal Research published by John W
wileyonlinelibrary.com/jopathogenesis, when attempting to explain the complex nature of this
disease. MMP polymorphisms have been of interest because of the
essential role of MMPs in periodontal tissue remodeling and destruc-
tion. MMP‐8 (neutrophil collagenase) is the most abundant and impor-
tant biomarker in periodontitis reflecting the initiation and progression
of the disease. Increased MMP‐8 levels reflect the severity and course
of periodontitis (Sorsa et al., 2016; Sorsa, Tjäderhane, & Salo, 2004;
Sorsa et al., 2006). In smokers, salivary MMP‐8 concentrations are
usually lower than in non‐smokers, even in adolescents (Liede et al.,
1999; Heikkinen et al., 2010).
The roles of MMP‐2, MMP‐8, MMP‐9, and MMP‐12 have been
analyzed with respect to the genetic polymorphisms; they maycense, which permits use, distribution and reproduction in any medium, provided
iley & Sons Ltd.
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HEIKKINEN ET AL. 209contribute to the susceptibility to periodontitis. MMP3 and tissue
inhibitor of MMPs (TIMP1) SNPs have also been considered as possi-
ble candidates in the pathogenesis of periodontitis (Letra et al., 2012;
Emingil et al., 2014). However, regarding matrix metallopeptidase 9
(MMP9) gene polymorphism, the results are ambivalent. Gürkan et al.
(2008) reported that carrier status of MMP9 ‐1562 T allele was lower
in healthy Turkish subjects than in chronic periodontitis group (Gürkan
et al., 2008). However, MMP9 ‐1562C/T was not related to the sus-
ceptibility to chronic periodontitis according to Holla, Fassmann,
Muzík, Vanek, and Vasku (2006) and de Souza et al. (2005). Interleu-
kins (IL) are pro‐inflammatory cytokines expressed mostly by leuko-
cytes. Interleukin‐6 (IL‐6) is secreted by various cell types and has
been shown to be important pro‐ and anti‐inflammatory mediator
involved also in the pathogenesis of periodontitis by regulating the
expression of IL‐1 and tumor necrosis factor alpha (TNF‐α) (Opal &
DePalo, 2000). It also stimulates osteoclast differentiation as well as
enhances B‐ and T‐cell growth, differentiation, and bone resorption
(Hughes, Turner, Belibasakis, & Martuscelli, 2006). An association
between the carriage rates of the IL‐1, Alpha (IL1A‐889, rs1800587),
and periodontitis has been demonstrated (Laine, Loos, & Crielaard,
2010). Other salivary inflammatory biomarker candidate genes for
periodontitis are considered, such as myeloperoxidase (MPO‐463G/A)
(Erciyas, Pehlivan, Sever, & Orbak, 2010) and calcium‐binding protein
A8 (S100A8) (Sun et al., 2011), Vitamin D (1,25‐Dihydroxyvitamin
D3) receptor (VDR) (Chen, Li, Zhang, & Wang, 2012; Laine et al.,
2012), toll‐like receptor 2, 4 (Folwaczny, Glas, Török, Limbersky, &
Folwaczny, 2004; Schröder & Schumann, 2005), and lymphotoxin
alpha (LTA) (Vasconcelos et al., 2012). However, studies on these cyto-
kine and inflammatory mediator polymorphisms are rare, and the
results are contradictory.
In Finland, 48% of the 30‐ to 34‐year‐olds have periodontitis
(Suominen‐Taipale et al., 2008). According to the thesis by Heikkinen
(2011) and Heikkinen et al. (2008), 56% of one birth cohort aged 15‐
to 16‐year‐old adolescents had more than one ≥4 mm periodontal
pockets (Heikkinen, 2011; Heikkinen et al., 2008). Taking into account
attachment loss and bleeding on probing, 10% of the subjects had
initial periodontitis, and most of them were smokers (Heikkinen,
2011; Heikkinen et al., 2008). Heikkinen et al. (2010, 2011, 2012 also
observed that smokers (25% of all participants) frequently harbored
more periodontal bacteria than non‐smokers (66%), and smoking
significantly decreased the values of the salivary biomarkers MMP‐8FIGURE 1 Study flow of the participantsand polymorphonuclear leukocytes (PMN) elastase in boys (Heikkinen
et al., 2010; Heikkinen, 2011; Heikkinen et al., 2012).
The aim of the present study was to examine the association
between the polymorphisms in salivary anti‐ and pro‐inflammatory
mediators and initial periodontitis. We hypothesized that the salivary
anti‐ and pro‐inflammatory mediator polymorphisms are associated
with initial periodontitis.1 | MATERIAL AND METHODS
1.1 | Study participants
Data were collected at the Kotka Health Center in Eastern Finland. The
study was approved by the Ethical Committee of the Helsinki and
Uusimaa Hospital District (Dnro 260/13/03/00/13). All the partici-
pants gave written informed consent. This study includes data from
two Finnish adolescent birth cohorts collected at the Kotka Health
Center in Eastern Finland in 2004–2005 and 2014–2015. Altogether,
there were 94 participants for whom we had available saliva and
DNA samples and who gave their approval for the saliva and DNA
analyses (see Figure 1 for study flow of the participants).
Oral health of subjects was clinically examined in both cohorts.
No periodontal therapy has been performed in the last recent year
among these participants before this study, and after diagnostic pro-
cedures, they were treated by specialist in clinical periodontics. In
short, periodontal parameters were recorded according to the
WHO recommendations (World Health Organization, International
Statistical Classification of Diseases and Related Health Problems, ).
Periodontal probing depth (PPD), bleeding on probing (BOP), and
visible plaque index (VPI) were recorded at four sites per tooth,
and all sites with ≥4 mm PD were recorded and categorized as
follows: PPD1 = one or more ≥4 mm pocket, PPD2 = two or more
≥4 mm pockets, and PPD3 = three or more ≥4 mm pockets
(Heikkinen et al., 2016). The cut‐point of the BOP value was 20 per-
centage meaning as gingivitis (Heikkinen, 2011; Heikkinen et al.,
2008). Root calculus (RC) and VPI were recorded from index teeth.
Smoking habits (cigarettes per week indicated regular smoking)
and pack‐years were recorded (Heikkinen et al., 2012). Stimulated
salivary samples were collected and centrifuged, and the supernatants
were used for the enzyme measurements, such as MMP‐8 analysis.
210 HEIKKINEN ET AL.MMP‐8 levels were analyzed by immunofluorometric assay (Medix
Biochemica, Kauniainen, Finland). The interassay coefficient of varia-
tion (CV)% for this study was 6.3%, and detection limit for the assay
was 0.08 μg/l (Heikkinen et al., 2010).1.2 | Candidate gene and SNP selection
Genetic variants for genotypingwere selected from the following genes
of interest: S100A8, Fc fragment of IgG, low affinity IIa, receptor
(FCGR2A), Fc fragment of IgG, low affinity IIb, receptor (FCGR2B), prosta-
glandin‐endoperoxide synthase 2 (PTGS2), IL10, MMP8, MMP3, MMP13,
VDR, tumor necrosis factor (TNF; ligand) superfamily, Member 11
(TNFSF11), toll‐like receptor 4 (TLR4), MMP2, MPO, elastase, neutrophil
expressed (ELANE), IL‐1, IL1A, Beta (IL1B), interleukin 1 receptor antago-
nist (IL1RN), CD28 molecule (CD28), MMP9, DEAD (Asp‐Glu‐Ala‐Asp)
box polypeptide 39B (DDX39B), nuclear factor of Kappa light polypeptide
gene enhancer in B‐cells inhibitor‐like 1 (NFKBIL1), LTA, TNF, Superoxide
Dismutase 2, Mitochondrial (SOD2), IL6, TIMP metallopeptidase inhibitor
1 (TIMP1), and Synapsin I (SYN1). The majority of SNPs were selected
based on previous publications. Some of the originally selected SNPs
failed the Sequenom iPLEX design because of technical reasons. For
these genes (ELANE, IL1B, IL1RN, DDX39B), replacing SNPs were
selected from the HapMap database (http://www.hapmap.org) by use
of the tag SNP selection algorithm Tagger included in the Haploview
4.2 software (Nature, 2003; Barrett, Fry, Maller, & Daly, 2005). Taq
SNP selection was used in order to select optimal SNPs covering most
of the genetic variation in the genomic area of interest. Flanking areas
of the size of 10 kb were included both upstream and downstream of
the actual gene encoding regions. Taq SNPs were selected based on
the criteria of minor allele frequency (MAF) >0.05 in European popula-
tion and pair‐wise r2 threshold of 0.9. Based on these selection criteria,
74 SNPs were successfully included in three genotyping multiplexes.
Three SNPs (rs3795391, rs2125685, and rs2544480) were excluded
during the optimization phase of genotyping. Table 1 gives all the SNPs
successfully genotyped in this study.1.3 | DNA extraction and genotyping
All saliva samples in both cohorts were immediately frozen at −20°C
and kept at −70°C until DNA extraction in both cohorts. DNA was
extracted from 300 μl of the saliva using a genomic QIAamp® DNA
Blood Mini Kit. Genotyping was performed using the Agena
MassARRAY SNP genotyping system and iPLEX Gold assays (Agena
Bioscience, San Diego, CA, USA). Allele discrimination is based on
primer extension with single mass‐modified nucleotides followed by
Matrix‐assisted laser desorption/ionization Time‐of‐Flight (MALDI‐
TOF) mass spectrometry. All reactions were designed in multiplexes
of up to 35 SNPs, by use of Assay Design v2.0 software (Agena Biosci-
ence). Genotyping reactions were performed on 20 ng of dried geno-
mic DNA in 384‐well plate format according to the manufacturer's
recommendations. Concentrations of the extension primers were
adjusted according to their mass and varied between 7 and 24.6 μM.
The data was collected using the MassARRAY Compact System (Agena
Bioscience), and the genotypes were identified using Typer 4 software
(Agena Bioscience). For quality control reasons, the genotype callswere also checked manually and corrected when necessary.
Genotyping quality was examined by a detailed QC procedure
consisting of success rate checks, duplicated samples, gender check
for X‐chromosomal markers, water controls, and Hardy–Weinberg
Equilibrium (HWE) testing.
Genotyping success rates ranged from 90.3% to 98.9%. All dupli-
cate samples gave concordant results. One subject was excluded
because of discrepant gender check results. Table 1 gives the genotype
and allele frequencies and HWE p‐values. Five SNPs turned out to be
non‐polymorphic (rs16062, rs315935, rs4251998, rs17216656, and
rs1062849). Three SNPs (rs5004021, rs4252022, and rs17223045)
with MAF < 0.01 were excluded. Rs5906435 and rs6520279 are
X‐chromosomal explaining their deviation from the HWE. All other
SNPs were in HWE (p > 0.01). Finally, 93 subjects and 63 SNPs were
included in the statistical analysis.1.4 | Statistical analysis
The association between dichotomic outcome variables (salivary
MMP‐8 > 163 μg/l, median value, BOP > 20%, RC > median, PPD1,
PPD2, and PPD3) and SNPs were modeled using logistic regression
model. For continuous outcome (PPD total), linear regression model
was used. We assumed additive effect of SNPs. For all outcomes,
two models were calculated: unadjusted with SNP as only explanatory
variable, and VPI, regular smoking (i.e., those who reported weekly
smoking), and two separate occasions for birth cohorts adjusted model.
All data analyses were carried out using R language (http://www.R‐
project.org) with package “SNPassoc”(R Development Core Team. R:
A Language and Environment for Statistical Computing. Vienna,
Austria, 2011). P values for each variable separately were corrected
using false discovery rate (FDR) correction (Benjamini & Hochberg,
1995; Glickman, Rao, & Schultz, 2014). FDR q‐values less than 0.05
were considered significant. Population stratification or relatedness
was not addressed.1.5 | Comparison of allele frequencies between
populations
Allele frequencies of the SNPs with statistically significant findings
(rs679620, rs520540, rs639752, rs3116496, and rs2228570) were
compared with allele frequencies given in the ExAC database (http://
exac.broadinstitute.org/). Frequencies for SNP rs639752 were not
found in the ExAC database, thus they were searched for HapMap‐
CEU from dbSNP database (http://www.ncbi.nlm.nih.gov/SNP/). In
addition, the frequencies were compared with American population
(1000 genomes AMR (1000 Genomes Ad Mixed American, including
populations:MXL, PUR, CLM, PEL) andHAPMAP‐MEX (Mexican ances-
try in Los Angeles, California), obtained from dbSNP database (Table 2).2 | RESULTS
Saliva MMP‐8 median values were calculated and appeared to be
163.1 μg/l. However, no statistical significant findings were observed
between salivary MMP‐8 median values and SPNs, which were ana-
lyzed in this study (Table 1).
TABLE 1 Successfully genotyped SNPs
Marker
Chr. location
(GRCh37) Gene
Alleles
(A1/A2) A1A1 (n, %) A1A2 (n, %) A2A2 (n, %) MAF, %
HWE
p‐value
rs3806232 1:153364130 S100A8 T/C 78 (85.7) 10 (11.0) 3 (3.3) 8.8 0.02
rs1801274 1:161479745 FCGR2A T/C 23 (25.6) 50 (55.6) 17 (18.9) 46.7 0.40
rs5275 1:186643058 PTGS2 T/C 39 (45.4) 39 (45.4) 8 (9.3) 32.0 0.81
rs689466 1:186650751 PTGS2 A/G 59 (64.8) 30 (33.0) 2 (2.2) 18.7 0.73
rs1800872 1:206946407 IL10 C/A 52 (56.5) 36 (39.1) 4 (4.4) 23.9 0.58
rs1800871 1:206946634 IL10 C/T 52 (56.5) 36 (39.1) 4 (4.4) 23.9 0.58
rs1800896 1:206946897 IL10 A/G 29 (31.5) 46 (50.0) 17 (18.5) 43.5 1.00
rs1800587 2:113542960 IL1A C/T 48 (52.2) 35 (38.0) 9 (9.8) 28.8 0.46
rs3917365 2:113586469 IL1B C/T 79 (86.8) 11 (12.1) 1 (1.1) 7.1 0.37
rs1143633 2:113590467 IL1B G/A 45 (49.5) 43 (47.3) 3 (3.3) 26.9 0.07
rs16062 2:113591081 IL1B C/T 92 (100) 0.0
rs1143627 2:113594387 IL1B T/C 35 (38.5) 43 (47.3) 13 (14.3) 37.9 1.00
rs16944 2:113594867 IL1B G/A 35 (39.3) 42 (47.2) 12 (13.5) 37.1 1.00
rs4251961 2:113874467 IL1RN T/C 42 (46.2) 40 (44.0) 9 (9.9) 31.9 1.00
rs4251985 2:113877413 IL1RN G/T 48 (52.8) 29 (31.9) 14 (15.4) 31.3 0.02
rs3213448 2:113879297 IL1RN G/A 62 (67.4) 26 (28.3) 4 (4.4) 18.5 0.50
rs315935 2:113881365 IL1RN A/G 85 (100) 0.0
rs4251998 2:113881962 IL1RN G/A 88 (100) 0.0
rs3181051 2:113884673 IL1RN C/T 87 (94.6) 5 (5.4) 0 2.7 1.00
rs3087263 2:113885768 IL1RN G/A 85 (93.4) 5 (5.5) 1 (1.1) 3.9 0.11
rs3087266 2:113889100 IL1RN C/T 55 (60.4) 28 (30.8) 8 (8.8) 24.2 0.15
rs4252022 2:113890161 IL1RN G/A 89 (98.9) 1 (1.1) 0 0.6 1.00
rs315952 2:113890304 IL1RN T/C 41 (44.6) 32 (34.8) 19 (20.7) 38.0 0.01
rs3116496 2:204594512 CD28 T/C 66 (72.5) 21 (23.1) 4 (4.4) 15.9 0.23
rs160690 6:2799060 DDX39B G/T 56 (61.5) 30 (33) 5 (5.5) 22.0 0.76
rs7766569 6:2807359 DDX39B A/G 52 (61.2) 32 (37.7) 1 (1.2) 20.0 0.17
rs5004021 6:2807721 DDX39B C/T 90 (98.9) 1 (1.1) 0 0.6 1.00
rs12525298 6:2810889 DDX39B C/T 53 (57.6) 35 (38.0) 4 (4.4) 23.4 0.77
rs186396 6:2811850 DDX39B A/G 23 (25.3) 57 (62.6) 11 (12.1) 43.4 0.01
rs9405587 6:2812175 DDX39B T/G 55 (59.8) 33 (35.9) 4 (4.4) 22.3 1.00
rs4084090 6:31218835 Intergenic Chr. 6 T/C 86 (93.5) 5 (5.4) 1 (1.1) 3.8 0.11
rs2071591 6:31515799 NFKBIL1 C/T 38 (42.2) 44 (48.9) 8 (8.9) 33.3 0.48
rs2857708 6:31533606 LTA G/A 64 (69.6) 27 (29.4) 1 (1.1) 15.8 0.46
rs2009658 6:31538244 LTA C/G 62 (67.4) 29 (31.5) 1 (1.1) 16.9 0.45
rs1800629 6:31543031 TNF G/A 70 (76.1) 22 (23.9) 0 12.0 0.35
rs2736189 6:31564728 NCR3 C/T 62 (68.1) 28 (30.8) 1 (1.1) 16.5 0.45
rs4880 6:160113872 SOD2 T/C 30 (32.6) 47 (51.1) 15 (16.3) 41.9 0.83
rs5746092 6:160114311 SOD2 C/G 43 (46.7) 41 (44.6) 8 (8.7) 31.0 0.81
rs2758343 6:160114572 SOD2 G/T 30 (32.6) 48 (52.2) 14 (15.2) 41.3 0.53
rs1800796 7:22766246 IL6 G/C 90 (97.8) 2 (2.2) 0 1.1 1.00
rs1800795 7:22766645 IL6 G/C 34 (37.8) 41 (45.6) 15 (16.7) 39.4 0.66
rs11536889 9:120478131 TLR4 G/C 78 (84.8) 13 (14.1) 1 (1.1) 8.2 0.46
rs3765620 11:102595492 MMP8 A/G 36 (39.1) 46 (50.0) 10 (10.9) 35.9 0.50
rs1320632 11:102596063 MMP8 T/C 81 (88.0) 11 (12.0) 0 6.0 1.00
rs11225395 11:102596480 MMP8 G/A 36 (39.1) 46 (50.0) 10 (10.9) 35.9 0.50
rs639752 11:102707339 MMP3 T/G 34 (37.4) 46 (50.6) 11 (12.1) 37.4 0.51
rs650108 11:102708787 MMP3 G/A 44 (47.8) 40 (43.5) 8 (8.7) 30.4 1.00
rs520540 11:102709425 MMP3 G/A 35 (38.0) 46 (50.0) 11 (12.0) 37.0 0.65
rs679620 11:102713620 MMP3 G/A 34 (40.5) 41 (48.8) 9 (10.7) 35.1 0.63
rs522616 11:102715048 MMP3 A/G 51 (56.0) 36 (39.6) 4 (4.4) 24.2 0.57
(Continues)
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TABLE 1 (Continued)
Marker
Chr. location
(GRCh37) Gene
Alleles
(A1/A2) A1A1 (n, %) A1A2 (n, %) A2A2 (n, %) MAF, %
HWE
p‐value
rs2252070 11:102826539 MMP13 A/G 25 (27.2) 52 (56.5) 15 (16.3) 44.6 0.21
rs7975232 12:48238837 VDR A/C 22 (23.9) 54 (58.7) 16 (17.4) 46.7 0.14
rs1544410 12:48239835 VDR G/A 47 (52.2) 34 (37.8) 9 (10.0) 28.9 0.45
rs2228570 12:48272895 VDR C/T 39 (42.4) 40 (43.5) 13 (14.1) 35.9 0.65
rs9533156 13:43147671 TNFSF11 C/T 23 (26.1) 44 (50.0) 21 (23.9) 48.9 1.00
rs2277438 13:43155168 TNFSF11 A/G 56 (61.5) 31 (34.1) 4 (4.4) 21.4 1.00
rs498670 13:91763380 TLR4 G/A 30 (33.0) 49 (53.9) 12 (13.2) 40.1 0.28
rs243865 16:55511806 MMP2 C/T 47 (51.1) 38 (41.3) 7 (7.6) 28.3 1.00
rs2759 17:56348106 MPO A/G 85 (92.4) 6 (6.5) 1 (1.1) 4.4 0.15
rs11575868 17:56352883 MPO G/A 79 (85.9) 13 (14.1) 0 7.1 1.00
rs2856857 17:56357833 MPO C/T 69 (75.0) 21 (22.8) 2 (2.2) 13.6 0.67
rs2243828 17:56358884 MPO A/G 63 (69.2) 24 (26.4) 4 (4.4) 17.6 0.46
rs2243827 17:56358941 MPO G/T 69 (75.8) 20 (22.0) 2 (2.2) 13.2 0.65
rs740021 19:852104 ELANE G/T 88 (96.7) 3 (3.3) 0 1.7 1.00
rs17223045 19:855587 ELANE C/T 90 (98.9) 1 (1.1) 0 0.6 1.00
rs17216656 19:856015 ELANE G/A 92 (100) 0.0
rs17576 20:44640225 MMP9 A/G 27 (30.0) 48 (53.3) 15 (16.7) 43.3 0.52
rs3787268 20:44641731 MMP9 G/A 55 (60.4) 34 (37.4) 2 (2.2) 20.9 0.34
rs1062849 X:47445999 TIMP1 C/T 92 (100) 0.0
rs6520279 X:47448096 SYN1 T/C 50 (54.4) 17 (18.5) 25 (27.2) 36.4 0.00
rs5906435 X:47448410 SYN1 C/T 54 (58.7) 16 (17.4) 22 (23.9) 32.6 0.00
Chromosomal location (assembly Feb. 2009 (GRCh37/hg19), associated gene, alleles, genotype counts and frequencies, minor allele frequencies (MAF) and
Hardy–Weinberg equilibrium (HWE) p‐values are given for each SNP.
212 HEIKKINEN ET AL.Of the subjects (n = 94), 18 were healthy (BOP < 20% and
no ≥ 4 mm pockets), 15 subjects had gingivitis (BOP ≥ 20% and
no ≥ 4 mm pockets), and 61 had one or more ≥4 mm pocket (PPD1).
Fifty‐one subjects had two or more ≥4 mm pockets (PPD2) and 37
had three or more ≥4 mm pockets (PPD3). Table 3 gives the basic char-
acteristics of the study population.
The following results were obtained on the genetic polymorphism
and periodontal disease clinical parameters and biomarkers. After false
discovery rate control (FDR, q < 0.05) only for PPD3 (three or more
≥4 mm pockets) and MMP‐3 (rs679620, rs520540, and rs639752),
PPD3 and CD28 (rs3116496) and PPD3 and VDR (rs2228570) were
statistically significant (q = 0.04, 0.04, 0.04, and 0.04, respectively).
Smoking or VPI did not affect these results. The significant results for
the adjusted model are given in Table 4, and all association results (all
phenotypes and both models) are given in the Supporting Information.
Allele frequencies of the five SNPs with statistically significant
findings (rs679620, rs520540, rs639752, rs3116496, and rs2228570)
were compared with allele frequencies in Finnish, European, and
American populations (ExAC, HAPMAP‐CEU, 1000 genomes AMR
and HAPMAP‐MEX). No major population specific allele differences
were detected.3 | DISCUSSION
The main finding of this study was that three MMP3 SNPs (rs67620,
rs520540, and rs639752) were associated as exposure agents withthree or more at least 4‐mm deep periodontal pockets by the strict sta-
tistical analysis (FDR). Interestingly, the same SNPs have previously
been significantly associated to chronic adult periodontitis (rs679620
in US Caucasians), rs520540 on a trend level in US Caucasians, and
rs639752 in US Caucasians and Brazilians (Letra et al., 2012). Our
results also showed that those with clinical signs of initial periodontitis
were separated from the healthy ones using the same definitions as in
our previous publications of the whole cohort (Heikkinen et al., 2010;
Heikkinen, 2011; Heikkinen et al., 2008; Heikkinen et al., 2016).
Stromelysin‐1 (MMP‐3) is involved in periodontal extracellular
matrix processing of the basal membrane as well as theMMP activation
cascades (Sorsa et al., 2004; Uitto, Overall, & McCulloch, 2003). Fibro-
blasts, chondrocytes, and endothelial cells can produce MMP‐3 as a
part of inflammatory tissue destruction cascades (Haerian,
Adonogianaki, Mooney, Docherty, & Kinane, 1995; Alpagot, Bell,
Lundergan, Chambers, & Rudin, 2001; Reynolds, Hembry, & Meikle,
1994). Increased MMP‐3 levels in gingival crevicular fluid reflecting
the course and severity of periodontitis have also been reported by
Toyman et al. (2015) in adult periodontitis patients (Toyman et al.,
2015). Previously, Ding et al. (2015) reported in their meta‐analysis that
MMP3 ‐1171 5A/6A polymorphism (rs35068180, not studied here)
could be associated with decreased risk of periodontitis in an Asian
population (Ding et al., 2015); however, Itagaki et al. (2004) pointed
that MMP‐3 gene promoter polymorphisms did not influence the sus-
ceptibility to periodontitis in Japanese patients (Itagaki et al., 2004).
Another finding of this study was that CD28 SNP rs3116496 [also
known as +17(T/C)] major allele T associated with PPD3 in the
TABLE 3 General characteristics of the participants with non‐missing DNA sample (n = 94)
n % Missing (n)
Male gender 47 50
Female gender 47 50
MMP‐8 > 163 μg/l 30 52.6 37
BOP > 20% 54 57.4
RC > median 5.85 47 50
Smoking regularly # 16 17
PPD1 61 64.9
PPD2 51 54.3
PPD3 37 39.4
Min. Max. Median Mean SD Missing (n)
Age 15 17 15 15.51 0.76
MMP‐8 μg/l 2.42 1147 163.1 176.4 165.9 37
BOP% 0.6 80.4 32.1 32.82 24.6
VPI % 0 95.8 27.55 31.67 24.6
RC % 0 79.2 5.85 9.52 12.6
PPD total 0 32 2 4 5.8
#Smoking weekly.
BOP = bleeding on probing; RC = root calculus; PPD1 = one or more ≥4mm pocket; PPD2 = two or more ≥4 mm pockets; PPD3 = three or more ≥4 mm
pockets; VPI = visible plaque index.
TABLE 2 Comparison of allele frequencies between populations for SNPs with significant findings
SNP
Allels
(Major/minor) MAF ExAC HapMap‐CEU AMR HapMap‐MEX Letra et?al. (Brazil) # Letra et?al. (US) #
rs679620 G/A 0.37 (A) 0.40 0.59 0.32 — 0.48 0.41
rs520540 G/A 0.37 (A) 0.39 0.57 0.34 — 0.49 0.43
rs639752 T/G 0.38 (G) — 0.57 0.34 0.35 0.48 0.51
rs3116496 T/C 0.16 (C) 0.14 0.17 0.11 0.13
rs2228570 A/G 0.34 (A) 0,36 0.41 0.48 0.52
MAF = minor allele frequency, minor allele given in parentheses; ExAC frequency given for European (Finnish) population; HapMap‐CEU = Utah residents
with northern and western European ancestry from the CEPH collection; AMR = ad mixed American population; Mexican ancestry in Los Angeles, California.
#Letra et?al. (2012), ref.no7.
TABLE 4 All significant (FDR q < 0.05) SNP associations between the analyzed SNPs and phenotypes of the VPI and weekly smoking adjusted
model. Major alleles were used as reference
Phenotype Gene SNP Allele OR Lower Upper p‐value FDR q‐value
PPD3 MMP3 rs679620 A 0.22 0.09 0.57 0.0006 0.04
PPD3 MMP3 rs520540 A 0.31 0.14 0.69 0.0020 0.04
PPD3 MMP3 rs639752 G 0.34 0.15 0.73 0.0036 0.04
PPD3 CD28 rs3116496 C 0.20 0.06 0.64 0.0015 0.04
PPD3 Vitamin D receptor rs2228570 T 2.85 1.39 5.83 0.0024 0.04
P‐value obtained from logistic regression corrected for multiple testing by false discovery rate (FDR).
PPD3 = three or more ≥4 mm pockets.
HEIKKINEN ET AL. 213adolescents. Previously, the polymorphism did not show any associa-
tion with periodontitis in adults (e Silva et al., 2013). However, among
non‐smokers, they reported a higher frequency of the T− (CC) geno-
type in aggressive periodontitis compared with chronic periodontitis.
Furthermore, we observed that Vitamin D receptor SNP
rs2228570 (also known as FokI) major allele C (also known as F allele)
was protective to PPD3. In line, Naito et al. (2007) reported that
heterozygous Ff individuals had a lower risk of severe chronic peri-
odontitis than individuals without the F allele (Naito et al., 2007). On
the contrary, Li et al. (2008) reported that F allele increased thesusceptibility of aggressive periodontitis in Chinese (Li et al., 2008)
and Park, Nam, and Choi (2006) reported that CC genotype associated
with increased risk for generalized aggressive periodontitis in Koreans
(Park et al., 2006). However, several studies have also reported no
association between rs2228570 and periodontis (Wang, Zhang, &
Chen, 2015; Wang et al., 2009; El Jilani et al., 2015; Tachi et al., 2003).
Laine et al. (2012) pointed in their review article that an associa-
tion could be found between periodontitis and haplotypes in theIL4
and IL6 and VDR genes (Laine et al., 2012). Earlier, Kornman et al.
(1997) observed that “severe periodontitis patients were accounted
214 HEIKKINEN ET AL.for by either smoking or the IL‐1 genotype” (Kornman et al., 1997). In
our study, no such effects could be seen; in our study only 17% were
regular smokers, and thus this potential confounding factor could not
be detected. In this respect, cytokine gene polymorphisms are
observed to be quite ambivalent.
However, as a limitation of this study of adolescents, the sample
size was quite small. Majority of the participants were lost because in
Finland it is difficult to obtain permission from adolescents and their
parents for a genetic study. This study has several strengths such as
comprehensive oral health examination, unique age group, and adoles-
cents. Despite the strengths, the limited sample size needs to be
acknowledged.
To conclude, our study was the first to investigate in an adolescent
population the genetic background of pathogenesis of initial or early
periodontitis. We found that the genetic polymorphisms in MMP3,
CD28, or VDR gene seem to be important in this respect, otherwise
than MMP8 gene, as might be assumed (Holla, Hrdlickova, Vokurka, &
Fassmann, 2012). However, more investigations are needed in larger
materials for final conclusion. Further, new point‐of‐care chair‐side
diagnostic tools have been developed to conveniently and consistently
identify those adolescents with elevated risk for ongoing active gingi-
vitis and periodontitis to be guided to regular examination and treat-
ments (Heikkinen et al., 2016). Nevertheless, our study hypothesis
was confirmed by showing an association between genetic polymor-
phism and periodontal disease parameters and markers.
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